-
The first generic! Osekon Pharmaceuticals TPO-R agonisant is listed
Time of Update: 2020-07-24
According to the latest public announcement by the Drug Review Center (CDE) of the State Drug Administration of China, Osekang Pharmaceuticals submitted an application for the listing of apopamatablet
-
Nature Sub-Journal: Drug screening combined with CRISPR technology to improve the efficacy of anti-cancer drugs
Time of Update: 2020-07-17
this further understanding of the biological mechanisms supporting drug response will help us develop new cancer drugs more quickly and effectively, and bring us closer to the precise treatment of cancer patients.
-
The introduction of the new policy makes it more convenient to sell medicines in convenience stores
Time of Update: 2020-07-12
Speeding up the development of chain convenience stores Simplifying the procedures for approval of operations Last August, the General Office of the State Council issued the Opinions on Speeding Up t
-
3 new three-plate pharmaceutical companies turn to the branch of the board! Cofeiping, Jiang bio, Jinbo bio IPO accepted
Time of Update: 2020-06-16
Recently, Applications from Jiangsu Kofipin Pharmaceutical Co., Ltd (hereinafter referred to as Kofiping), Shanghai Jiang Biotech Co., Ltd (hereinafter referred to as Jiangbio) and Shanxi Jinbo Biopha
-
First-line treatment of lung cancer! Baxter-American O-Y combination chemotherapy 3 clinical reached the main end
Time of Update: 2020-06-01
Opdivo-Yervoy, BMS's immunooncology portfolio, has suffered in untreated non-small cell lung cancer trials, but the program is likely to succeed after adding new members October 22, BMS announced a k
-
Since September this year, 33 pilot county hospitals in Fujian have achieved zero drug price differentials
Time of Update: 2020-05-12
since September this year, fujian 33 pilot counties hospitals achieve the drug zero price time: 2014-06-21 08:23:35 Source: Straits Metropolis Daily ( 0 ) yesterday, the province's county-leve
-
Hengrui shr7390 tablet and Baiji Shenzhou bgb-3111 capsule were approved for clinical use
Time of Update: 2020-04-03
The clinical application of class 1.1 new drugs of shr7390 tablets entered CFDA drug review center on December 31, 2014, and took a special review channel Shr7390 is a MEK kinase inhibitor developed f
-
burst! The first imitation of lanthanum carbonate will be approved soon
Time of Update: 2020-02-24
On February 21, according to the nmpa website, the application for listing of six generic Lanthanum Carbonate Chewable Tablets of Hunan Mingrui Pharmaceutical Co., Ltd has been approved According to t
-
What innovative therapies will the Nobel Prize winning "oxygen sensing pathway" bring
Time of Update: 2019-10-08
Yesterday, the 2019 Nobel Prize in physiology or medicine was announced Professor William g kaelin, Professor Peter J Ratcliffe, and Professor Gregg L Semenza were honored for their research on the cr
-
Acarbose capsule, a diabetes drug with a market value of nearly 10 billion, passed the consistency evaluation
Time of Update: 2019-06-04
LVYE Pharmaceutical Group announced that its core product "acarbose capsule" (trade name: Beixi) for the treatment of diabetes has been approved by the State Drug Administration and passed the quality
-
New hope for Alzheimer's disease! First in class drugs recognized by FDA acceleration channel
Time of Update: 2017-10-17
Source: on October 16, 2017, cognition therapeutics, a clinical neuroscience company focused on developing innovative therapies for Alzheimer's disease and other neurocognitive disorders, announced th
-
The special inspection of Chinese herbal extracts has started. These four illegal advertising drugs have been stopped
Time of Update: 2017-09-13
According to the work plan for the special inspection of traditional Chinese medicine extracts in Gansu Province, the provincial food and Drug Administration organized the special inspection of tradit
-
Three varieties in the generic conformity assessment 289 catalogue have been abandoned
Time of Update: 2017-08-07
Source: medical economic news 2017-08-07 Medical network, Aug 7, recently, the reporter learned from the "2017 high level seminar on the consistency evaluation of quality and efficacy of generic drugs
-
Approved clinical trial of tpn171, a new class 1.1 anti pulmonary hypertension drug from Shanghai Institute of Medicine
Time of Update: 2016-03-24
It is learned from Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences that tpn171 and its tablets, a new drug for the treatment of pulmonary hypertension (PAH) 1.1, independent
-
Drug centralized bidding is not a panacea
Time of Update: 2015-07-31
Source: on July 31, 2015, the pharmaceutical Observer newspaper held the 5th session of the 7th chairman's meeting of China Pharmaceutical Business Association in Shanghai recently Ye Hua, associate p
